Hua Lin

693 total citations
19 papers, 572 citations indexed

About

Hua Lin is a scholar working on Nephrology, Molecular Biology and Epidemiology. According to data from OpenAlex, Hua Lin has authored 19 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 10 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Hua Lin's work include Gout, Hyperuricemia, Uric Acid (9 papers), Renal Diseases and Glomerulopathies (4 papers) and Inflammasome and immune disorders (4 papers). Hua Lin is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (9 papers), Renal Diseases and Glomerulopathies (4 papers) and Inflammasome and immune disorders (4 papers). Hua Lin collaborates with scholars based in China, Hong Kong and United States. Hua Lin's co-authors include Lihui Gao, Yanfen Niu, Junbiao Wu, Jiuyao Zhou, Junqi Chen, Dandan Chen, Ruirui Lu, Ling Li, Xiaodan Wang and Bihao Liu and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and Journal of Cellular Physiology.

In The Last Decade

Hua Lin

19 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Lin China 15 205 185 111 103 81 19 572
Yonger Chen China 14 287 1.4× 116 0.6× 74 0.7× 48 0.5× 70 0.9× 20 609
Bingbing Zhu China 14 238 1.2× 137 0.7× 82 0.7× 48 0.5× 31 0.4× 50 609
Liping Bao China 7 285 1.4× 57 0.3× 63 0.6× 85 0.8× 130 1.6× 11 624
Enchao Zhou China 12 204 1.0× 105 0.6× 40 0.4× 44 0.4× 41 0.5× 25 487
Yilan Shen China 10 212 1.0× 99 0.5× 60 0.5× 40 0.4× 51 0.6× 20 453
Qiaoyan Guo China 12 195 1.0× 185 1.0× 46 0.4× 39 0.4× 48 0.6× 33 495
Yuebo Huang China 12 315 1.5× 123 0.7× 60 0.5× 33 0.3× 87 1.1× 14 587
Yue‐Rong Ma China 9 159 0.8× 55 0.3× 124 1.1× 56 0.5× 34 0.4× 15 476
Jiarong Gao China 14 250 1.2× 54 0.3× 52 0.5× 102 1.0× 44 0.5× 55 485

Countries citing papers authored by Hua Lin

Since Specialization
Citations

This map shows the geographic impact of Hua Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Lin more than expected).

Fields of papers citing papers by Hua Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Lin. The network helps show where Hua Lin may publish in the future.

Co-authorship network of co-authors of Hua Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Lin. A scholar is included among the top collaborators of Hua Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Lin. Hua Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pan, Banglun, et al.. (2023). 2,5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis. Journal for ImmunoTherapy of Cancer. 11(6). e006817–e006817. 29 indexed citations
2.
Liu, Yaoyu, Xiaojie Li, Yifan Wu, et al.. (2023). Macrophage-derived exosomes promote activation of NLRP3 inflammasome and autophagy deficiency of mesangial cells in diabetic nephropathy. Life Sciences. 330. 121991–121991. 31 indexed citations
3.
Niu, Yanfen, Qiang Li, Cai‐Xia Tu, et al.. (2023). Hypouricemic Actions of the Pericarp of Mangosteen in Vitro and in Vivo. Journal of Natural Products. 86(1). 24–33. 8 indexed citations
4.
Chen, Junqi, Lina Luo, Hua Lin, et al.. (2022). Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p/phosphatidylinositol 3-kinase/AKT pathway. Bioengineered. 13(5). 13956–13969. 20 indexed citations
5.
Chen, Dandan, Junqi Chen, Hua Lin, et al.. (2021). JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes. European Journal of Pharmacology. 902. 174121–174121. 63 indexed citations
6.
Lu, Ruirui, Junqi Chen, Bihao Liu, et al.. (2020). Protective role of Astragaloside IV in chronic glomerulonephritis by activating autophagy through PI3K/AKT/AS160 pathway. Phytotherapy Research. 34(12). 3236–3248. 21 indexed citations
7.
Niu, Yanfen, Hongjian Li, Qiang Li, et al.. (2020). Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals. Biological and Pharmaceutical Bulletin. 43(11). 1653–1659. 1 indexed citations
8.
Lin, Hua, Yanfen Niu, Yan Liu, et al.. (2020). Mangiferin promotes intestinal elimination of uric acid by modulating intestinal transporters. European Journal of Pharmacology. 888. 173490–173490. 14 indexed citations
9.
Lin, Hua, Cai‐Xia Tu, Yanfen Niu, et al.. (2019). Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition. European Journal of Pharmacology. 853. 371–380. 17 indexed citations
10.
Chen, Dandan, Rui Xu, Jiuyao Zhou, et al.. (2019). Cordyceps militaris polysaccharides exerted protective effects on diabetic nephropathy in mice via regulation of autophagy. Food & Function. 10(8). 5102–5114. 45 indexed citations
11.
Yang, Hua, Wenwei Bai, Lihui Gao, et al.. (2018). Mangiferin alleviates hypertension induced by hyperuricemia via increasing nitric oxide releases. Journal of Pharmacological Sciences. 137(2). 154–161. 28 indexed citations
12.
Wang, Xiaodan, Lihui Gao, Hua Lin, et al.. (2018). Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. European Journal of Pharmacology. 824. 170–178. 103 indexed citations
13.
Li, Ruilei, Haifeng Song, Tao Geng, et al.. (2017). Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC. BMC Cancer. 17(1). 884–884. 36 indexed citations
14.
Niu, Yanfen, Hongjian Li, Lihui Gao, et al.. (2017). Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity. Journal of Pharmacological Sciences. 135(3). 114–120. 12 indexed citations
15.
Wu, Junbiao, Yu He, Yining Luo, et al.. (2017). MiR‐145‐5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16. Journal of Cellular Physiology. 233(4). 3648–3659. 30 indexed citations
16.
Niu, Yanfen, Hua Lin, Lihui Gao, et al.. (2017). Inhibition of 3,5,2′,4′-Tetrahydroxychalcone on Production of Uric Acid in Hypoxanthine-Induced Hyperuricemic Mice. Biological and Pharmaceutical Bulletin. 41(1). 99–105. 11 indexed citations
17.
Yang, Hua, Lihui Gao, Yanfen Niu, et al.. (2015). Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental Hyperuricemia. Biological and Pharmaceutical Bulletin. 38(10). 1591–1598. 42 indexed citations
18.
Wang, Fang, Juming Yan, Yanfen Niu, et al.. (2013). Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. Pharmaceutical Biology. 52(1). 68–73. 35 indexed citations
19.
Niu, Yanfen, Wei Lu, Lihui Gao, et al.. (2012). Reducing effect of mangiferin on serum uric acid levels in mice. Pharmaceutical Biology. 50(9). 1177–1182. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026